LAB Standard BioTools Inc.
0.6787USD-6.00%Mkt Cap: 266.44M $P/E: —1d ago
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Amer…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap266.44M USD
Enterprise Value-165.19M USD
Revenue (TTM)84.60M USD
Gross Profit42.54M USD
Net Income (TTM)-74.90M USD
Revenue/Share0.22 USD
Last Price0.6787 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees385
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-72.20
PEG—
EV/EBITDA3.11
EV/Revenue-1.95
P/S3.35
P/B0.52
EPS (TTM)-0.12
EPS (Forward)-0.01
52W Range
0.62515% of range1.720
52W High1.720 USD
52W Low0.6251 USD
Profitability
Gross Margin49.86%
Oper. Margin-38.94%
EBITDA Margin-62.74%
Profit Margin-87.77%
ROE-17.65%
ROA-13.19%
Growth
Revenue Growth-7.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-74.34M USD
CapEx (TTM)8.30M USD
FCF Margin208.73%
FCF Yield66.27%
Net Debt-448.63M USD
Net Debt/EBITDA8.45
Balance Sheet
Debt/Equity0.07
Current Ratio9.10
Quick Ratio8.67
Book Value/Sh1.38 USD
Cash/Share1.21 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.350 USD
Upside (mean)+98.9%
Target Range1.350 USD – 1.350 USD
# Analysts1
Ownership
Shares Out.392.58M
Float184.62M
Insiders2.02%
Institutions75.87%
Short Interest
Short Ratio1.5d
Short % Float1.09%
Short % Out.0.66%
Shares Short2.59M
Short (prev mo.)2.41M
Technical
SMA 500.7296 (-7.0%)
SMA 2000.9883 (-31.3%)
Beta1.35
S&P 52W Chg16.45%
Avg Vol (30d)1.45M
Avg Vol (10d)855.82K
Technical Indicators
RSI (14)40.5
MACD-0.0044
MACD Signal-0.0045
MACD Hist.+0.0001
BB Upper0.7772 USD
BB Middle0.7255 USD
BB Lower0.6737 USD
BB Width14.27%
ATR (14)0.0450 USD
Vol Ratio (20d)1.15x